Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review

Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?

(2018) Cafer Balcı et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparative incidence and excess risk of acute kidney injury in hospitalized patients receiving vancomycin and piperacillin-tazobactam in combination or as monotherapy

(2018) Joseph J. Carreno et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

(2016) Andre C. Kalil et al.   CLINICAL INFECTIOUS DISEASES

Assessment of the RIFLE criteria for the diagnosis of Acute Kidney Injury; a retrospective study in South-Western Ghana

(2016) Richard K. D. Ephraim et al.   BMC Nephrology

Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011

(2014) Shelley S. Magill et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime

(2014) Diane M. Gomes et al.   PHARMACOTHERAPY

Vancomycin-Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors

(2014) Calvin J. Meaney et al.   PHARMACOTHERAPY